View Older Stories View More Recent Stories

May 6, 2026 09:01AM Eli Lilly invests additional $4.5 billion in Indiana manufacturing sites
May 5, 2026 12:30PM Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics
May 5, 2026 06:48AM Lilly's Omvoh shows sustained disease remission in ulcerative colitis study
May 4, 2026 11:14AM Eli Lilly & Co. (LLY) Declares $1.73 Quarterly Dividend; 0.7% Yield
May 4, 2026 10:26AM RBC Capital on Eli Lilly (LLY): 'we think the sell-off is overdone'
May 4, 2026 09:27AM Goldman Sachs on Eli Lilly (LLY): 'see the stock weakness as an overreaction'
May 4, 2026 09:20AM Guggenheim on Cabaletta Bio (CABA): 'compelling evidence that CAR-T activity can be achieved without preconditioning'
May 4, 2026 09:15AM Bernstein: We're buyers of weakness in LLY
May 4, 2026 08:58AM Eli Lilly (LLY) PT Raised to $1,400 at Barclays, 'A remarkably strong quarter...and LLY's only just getting started'
May 4, 2026 08:57AM Wolfe Research Defending Eli Lilly (LLY) Amid 1.53% Drop: 'Faers For Foundayo Are Unfounded'
May 4, 2026 08:44AM Why Eli Lilly stock is down 3% today: FDA adverse event data explained
May 1, 2026 11:06AM Eli Lilly (LLY) PT Lowered to $1,133 at BofA Securities
May 1, 2026 08:34AM Novo Nordisk rebrands diabetes tablet as Ozempic in US
May 1, 2026 07:13AM Eli Lilly (LLY) PT Raised to $1,230 at Cantor Fitzgerald
May 1, 2026 07:03AM Eli Lilly's oral weight loss drug sees over 5,600 prescriptions in third week
Apr 30, 2026 04:19PM Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
Apr 30, 2026 09:23AM FDA proposes to exclude semaglutide, tirzepatide from compounding list
Apr 30, 2026 07:21AM Lilly surges on earnings beat and raised guidance
Apr 30, 2026 06:48AM Eli Lilly & Co. (LLY) Tops Q1 EPS by $1.58, Beats on Revenue; Offers Strong Guidance
Apr 30, 2026 03:28AM Eli Lilly & Co. (LLY) call put ratio 1.1 calls to 1 put into quarter results
Apr 30, 2026 02:00AM Eli Lilly Q1 earnings preview: analysts eye outlook for obesity drugs
Apr 29, 2026 11:15AM Eli Lilly & Co. (LLY) call put ratio 1.1 calls to 1 put into quarter results
Apr 29, 2026 04:39AM Eli Lilly & Co. (LLY) call put ratio 1.5 calls to 1 put into quarter results
Apr 28, 2026 11:30AM Eli Lilly & Co. (LLY) call put ratio 1.3 calls to 1 put into quarter results
Apr 27, 2026 06:22AM Eli Lilly (LLY) PT Lowered to $$1,058 at Leerink Partners
Apr 25, 2026 04:00AM AI is starting to impact the pharma sector — These 2 stocks are seen as NT winners
Apr 24, 2026 07:27AM Morgan Stanley Comments on Eli Lilly (LLY) Amid Premarket Volatility
Apr 24, 2026 06:28AM Eli Lilly & Co. (LLY) shares trade lower on weak Foundayo launch
Apr 23, 2026 08:40AM Hims & Hers expands platform to include Eli Lilly weight loss medications
Apr 22, 2026 08:38AM Bernstein: Potential for Beat to Drive Eli Lilly (LLY) Stock
Apr 21, 2026 04:22PM Rigel Pharmaceuticals regains rights as Lilly terminates license deal
Apr 21, 2026 01:33PM Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
Apr 21, 2026 11:03AM Eli Lilly and Novo Nordisk shares fall as CVS opts out of Medicare obesity drug coverage
Apr 21, 2026 10:53AM CVS Health Opts Out Of Medicare Obesity Drug Coverage Model
Apr 21, 2026 09:41AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
Apr 21, 2026 07:19AM Bernstein SocGen Reiterates Outperform Rating on Eli Lilly (LLY)
Apr 20, 2026 11:20AM RBC Capital on Eli Lilly (LLY): Kelonia acquisition payment 'may appear full,' but strategically justified
Apr 20, 2026 10:51AM RBC on Legend Biotech Corp. (LEGN): 'We Think Shares Remain Undervalued'
Apr 19, 2026 05:26PM Eli Lilly & Co. (LLY) nears deal to acquire Kelonia Therapeutics - WSJ
Apr 17, 2026 09:57AM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)
Apr 17, 2026 08:14AM Guggenheim Reiterates Buy Rating on Eli Lilly (LLY)
Apr 16, 2026 11:07AM Leerink Partners now expects Eli Lilly's (LLY) Foundayo in diabetes to be approved in 2H26
Apr 16, 2026 08:40AM Walmart expands weight management services with virtual care platform
Apr 15, 2026 09:39AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Apr 14, 2026 08:07AM Eli Lilly to acquire CrossBridge Bio for up to $300 million
Apr 13, 2026 03:02PM Leerink stays Outperform on Eli Lilly (LLY) after Jaypirca Ph3 results
Apr 13, 2026 06:45AM Lilly's Jaypirca shows positive results in blood cancer trial
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 10, 2026 11:01AM Eli Lilly & Co. (LLY) call put ratio 2 calls to 1 put as share price down 1.7%
Apr 10, 2026 08:35AM RBC Capital 'Expecting GLP-1 Sales Strength' for Eli Lilly (LLY)
View More Recent Stories View Older Stories